BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23105021)

  • 21. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.
    Aguilar G; Delgado C; Corrales I; Izquierdo A; Gracia E; Moreno T; Romero E; Ferrando C; Carbonell JA; Borrás R; Navarro D; Belda FJ
    BMC Res Notes; 2015 Sep; 8():491. PubMed ID: 26415526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria.
    Beyer R; Spettel K; Zeller I; Lass-Flörl C; Achleitner D; Krause R; Apfalter P; Buzina W; Strauss J; Gregori C; Schüller C; Willinger B
    Mycoses; 2019 Apr; 62(4):357-367. PubMed ID: 30636016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
    Tasneem U; Siddiqui MT; Faryal R; Shah AA
    J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
    J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of
    Chen J; Hu N; Xu H; Liu Q; Yu X; Zhang Y; Huang Y; Tan J; Huang X; Zeng L
    Front Cell Infect Microbiol; 2021; 11():721439. PubMed ID: 34604110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal susceptibility profile of invasive
    Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
    J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections.
    Borghi E; Sciota R; Iatta R; Biassoni C; Montagna MT; Morace G
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1437-41. PubMed ID: 21479840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Ten-year Retrospective Study of Invasive Candidiasis in a Tertiary Hospital in Beijing.
    Yang ZH; Song YG; Li RY
    Biomed Environ Sci; 2021 Oct; 34(10):773-788. PubMed ID: 34782044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
    Cantón E; Pemán J; Quindós G; Eraso E; Miranda-Zapico I; Álvarez M; Merino P; Campos-Herrero I; Marco F; de la Pedrosa EG; Yagüe G; Guna R; Rubio C; Miranda C; Pazos C; Velasco D;
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
    Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
    Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
    González GM; Elizondo M; Ayala J
    J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.
    Hrabovský V; Takáčová V; Schréterová E; Pastvová L; Hrabovská Z; Čurová K; Siegfried L
    Folia Microbiol (Praha); 2017 Nov; 62(6):525-530. PubMed ID: 28361459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.
    De Francesco MA; Piccinelli G; Gelmi M; Gargiulo F; Ravizzola G; Pinsi G; Peroni L; Bonfanti C; Caruso A
    Mycopathologia; 2017 Oct; 182(9-10):897-905. PubMed ID: 28597394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Lindberg E; Hammarström H; Ataollahy N; Kondori N
    Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China.
    Zeng ZR; Tian G; Ding YH; Yang K; Liu JB; Deng J
    BMC Infect Dis; 2019 Nov; 19(1):939. PubMed ID: 31699043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.
    González GM; Treviño-Rangel Rde J; Palma-Nicolás JP; Martínez C; González JG; Ayala J; Caballero A; Morfín-Otero R; Rodríguez-Noriega E; Velarde F; Ascencio EP; Tinoco JC; Vázquez JA; Cano MA; León-Sicairos N; González R; Rincón J; Elías MA; Bonifaz A
    J Antimicrob Chemother; 2013 Dec; 68(12):2847-51. PubMed ID: 23869052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
    Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
    J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
    Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
    BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.
    Pfaller MA; Andes DR; Diekema DJ; Horn DL; Reboli AC; Rotstein C; Franks B; Azie NE
    PLoS One; 2014; 9(7):e101510. PubMed ID: 24991967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.